• 2024
  Dejoux A, Zhu Q, Ganneau C, Goff OR, Godon O, Lemaitre J, Relouzat F, Huetz F, Sokal A, Vandenberghe A, Pecalvel C, Hunault L, Derenne T, Gillis CM, Iannascoli B, Wang Y, Rose T, Mertens C, Nicaise-Roland P, , England P, Mahévas M, de Chaisemartin L, Le Grand R, Letscher H, Saul F, Pissis C, Haouz A, Reber LL, Chappert P, Jönsson F, Ebo DG, Millot GA, Bay S, Chollet-Martin S, Gouel-Chéron A, Bruhns P, Rocuronium-specific antibodies drive perioperative anaphylaxis but can also function as reversal agents in preclinical models., Sci Transl Med 2024 Sep; 16(764): eado4463.
• 2024
  Loot C, Millot GA, Richard E, Littner E, Vit C, Lemoine F, Néron B, Cury J, Darracq B, Niault T, Lapaillerie D, Parissi V, Rocha EPC, Mazel D, Integron cassettes integrate into bacterial genomes via widespread non-classical attG sites., Nat Microbiol 2024 Jan; 9(1): 228-240.
• 2022
  N'Gadjaga MD, Perrinet S, Connor MG, Bertolin G, Millot GA, Subtil A, , Chlamydia trachomatis development requires both host glycolysis and oxidative phosphorylation but has only minor effects on these pathways., J Biol Chem 2022 Aug; 298(9): 102338.
• 2022
  Theulot B, Lacroix L, Arbona JM, Millot GA, Jean E, Cruaud C, Pellet J, Proux F, Hennion M, Engelen S, Lemainque A, Audit B, Hyrien O, Le Tallec B, , Genome-wide mapping of individual replication fork velocities using nanopore sequencing., Nat Commun 2022 06; 13(1): 3295.
• 2022
  Canales-Herrerias P, Crickx E, Broketa M, Sokal A, Chenon G, Azzaoui I, Vandenberghe A, Perima A, Iannascoli B, Richard-Le Goff O, Castrillon C, Mottet G, Sterlin D, Robbins A, Michel M, England P, Millot GA, Eyer K, Baudry J, Mahevas M, Bruhns P, , High-affinity autoreactive plasma cells disseminate through multiple organs in patients with immune thrombocytopenic purpura., J Clin Invest 2022 May; (): .
• 2021
  Menegatti S, Guillemot V, Latis E, Yahia-Cherbal H, Mittermüller D, Rouilly V, Mascia E, Rosine N, Koturan S, Millot GA, Leloup C, Duffy D, Gleizes A, Hacein-Bey-Abina S, , Sellam J, Berenbaum F, Miceli-Richard C, Dougados M, Bianchi E, Rogge L, Immune response profiling of patients with spondyloarthritis reveals signalling networks mediating TNF-blocker function in vivo., Ann Rheum Dis 2021 Apr; 80(4): 475-486.
• 2021
  Marbouty M, Thierry A, Millot GA, Koszul R, , MetaHiC phage-bacteria infection network reveals active cycling phages of the healthy human gut., Elife 2021 Feb; 10(): .
• 2020
  Baudry L, Millot GA, Thierry A, Koszul R, Scolari VF, , Serpentine: a flexible 2D binning method for differential Hi-C analysis., Bioinformatics 2020 Jun; 36(12): 3645-3651.
• 2020
  Gérard A, Woolfe A, Mottet G, Reichen M, Castrillon C, Menrath V, Ellouze S, Poitou A, Doineau R, Briseno-Roa L, Canales-Herrerias P, Mary P, Rose G, Ortega C, Delincé M, Essono S, Jia B, Iannascoli B, Richard-Le Goff O, Kumar R, Stewart SN, Pousse Y, Shen B, Grosselin K, Saudemont B, Sautel-Caillé A, Godina A, McNamara S, Eyer K, Millot GA, Baudry J, England P, Nizak C, Jensen A, Griffiths AD, Bruhns P, Brenan C, High-throughput single-cell activity-based screening and sequencing of antibodies using droplet microfluidics, Nat. Biotechnol. 2020 Mar;.
• 2020
  Monteiro AN, Bouwman P, Kousholt AN, Eccles DM, Millot GA, Masson JY, Schmidt MK, Sharan SK, Scully R, Wiesmüller L, Couch F, Vreeswijk MPG, Variants of uncertain clinical significance in hereditary breast and ovarian cancer genes: best practices in functional analysis for clinical annotation, J. Med. Genet. 2020 Mar;.
• 2020
  Balbino B, Herviou P, Godon O, Stackowicz J, Goff OR, Iannascoli B, Sterlin D, Brûlé S, Millot GA, Harris FM, Voronina VA, Nadeau KC, Macdonald LE, Murphy AJ, Bruhns P, Reber LL, The anti-IgE mAb omalizumab induces adverse reactions by engaging Fcγ receptors, J. Clin. Invest. 2020 Mar;130(3):1330-1335.
• 2019
  Sanchez David RY, Combredet C, Najburg V, Millot GA, Beauclair G, Schwikowski B, Léger T, Camadro JM, Jacob Y, Bellalou J, Jouvenet N, Tangy F, Komarova AV, LGP2 binds to PACT to regulate RIG-I- and MDA5-mediated antiviral responses., Sci Signal 2019 Oct; 12(601): .
• 2019
  Chaussade A, Millot G, Wells C, Brisse H, Laé M, Savignoni A, Desjardins L, Dendale R, Doz F, Aerts I, Jimenez I, Cassoux N, Stoppa Lyonnet D, Gauthier Villars M, Houdayer C, Correlation between RB1germline mutations and second primary malignancies in hereditary retinoblastoma patients treated with external beam radiotherapy, Eur J Med Genet 2019 Mar;62(3):217-223.
• 2019
  Blin M, Le Tallec B, Nähse V, Schmidt M, Brossas C, Millot GA, Prioleau MN, Debatisse M, Transcription-dependent regulation of replication dynamics modulates genome stability, Nat. Struct. Mol. Biol. 2019 01;26(1):58-66.
• 2018
  Cossé MM, Barta ML, Fisher DJ, Oesterlin LK, Niragire B, Perrinet S, Millot GA, Hefty PS, Subtil A, The Loss of Expression of a Single Type 3 Effector (CT622) Strongly Reduces Infectivity and Growth, Front Cell Infect Microbiol 2018;8:145.
• 2018
  Millot Gael, Comprendre et réaliser les tests statistiques à l’aide de R, 4th edition, De Boeck editions, Bruxelles.
• 2017
  Benabou M, Rolland T, Leblond CS, Millot GA, Huguet G, Delorme R, Leboyer M, Pagan C, Callebert J, Maronde E, Bourgeron T, , Heritability of the melatonin synthesis variability in autism spectrum disorders., Sci Rep 2017 Dec; 7(1): 17746.
• 2017
  Golmard L, Castéra L, Krieger S, Moncoutier V, Abidallah K, Tenreiro H, Laugé A, Tarabeux J, Millot GA, Nicolas A, Laé M, Abadie C, Berthet P, Polycarpe F, Frébourg T, Elan C, de Pauw A, Gauthier-Villars M, Buecher B, Stern MH, Stoppa-Lyonnet D, Vaur D, Houdayer C, Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancers, Eur. J. Hum. Genet. 2017 12;25(12):1345-1353.
• 2016
  Dehainault C, Golmard L, Millot GA, Charpin A, Laugé A, Tarabeux J, Aerts I, Cassoux N, Stoppa-Lyonnet D, Gauthier-Villars M, Houdayer C, Mosaicism and prenatal diagnosis options: insights from retinoblastoma, Eur. J. Hum. Genet. 2017 02;25(3):381-383.
• 2016
  Thouvenot P, Fourrière L, Dardillac E, Ben Yamin B, Lescure A, Lejour V, Heiligenstein X, Boulé JB, Romao M, Raposo-Benedetti G, Lopez BS, Nicolas A, Millot GA, Yeast cells reveal the misfolding and the cellular mislocalization of the human BRCA1 protein, J. Cell. Sci. 2016 12;129(23):4366-4378.
• 2016
  Thouvenot P, Ben Yamin B, Fourrière L, Lescure A, Boudier T, Del Nery E, Chauchereau A, Goldgar DE, Houdayer C, Stoppa-Lyonnet D, Nicolas A, Millot GA, Functional Assessment of Genetic Variants with Outcomes Adapted to Clinical Decision-Making, PLoS Genet. 2016 06;12(6):e1006096.
• 2016
  Eloy P, Dehainault C, Sefta M, Aerts I, Doz F, Cassoux N, Lumbroso le Rouic L, Stoppa-Lyonnet D, Radvanyi F, Millot GA, Gauthier-Villars M, Houdayer C, A Parent-of-Origin Effect Impacts the Phenotype in Low Penetrance Retinoblastoma Families Segregating the c.1981C>T/p.Arg661Trp Mutation of RB1, PLoS Genet. 2016 Feb;12(2):e1005888.
• 2016
  Técher H, Koundrioukoff S, Carignon S, Wilhelm T, Millot GA, Lopez BS, Brison O, Debatisse M, Signaling from Mus81-Eme2-Dependent DNA Damage Elicited by Chk1 Deficiency Modulates Replication Fork Speed and Origin Usage, Cell Rep 2016 Feb;14(5):1114-1127.
• 2016
  De Carli F, Gaggioli V, Millot GA, Hyrien O, Single-molecule, antibody-free fluorescent visualisation of replication tracts along barcoded DNA molecules, Int. J. Dev. Biol. 2016;60(7-8-9):297-304.
• 2015
  Jhuraney A, Velkova A, Johnson RC, Kessing B, Carvalho RS, Whiley P, Spurdle AB, Vreeswijk MP, Caputo SM, Millot GA, Vega A, Coquelle N, Galli A, Eccles D, Blok MJ, Pal T, van der Luijt RB, Santamariña Pena M, Neuhausen SL, Donenberg T, Machackova E, Thomas S, Vallée M, Couch FJ, Tavtigian SV, Glover JN, Carvalho MA, Brody LC, Sharan SK, Monteiro AN, , BRCA1 Circos: a visualisation resource for functional analysis of missense variants, J. Med. Genet. 2015 Apr;52(4):224-30.
• 2014
  Millot Gael, Comprendre et réaliser les tests statistiques à l’aide de R, 3rd edition, De Boeck editions, Bruxelles.
• 2013
  Le Tallec B, Millot GA, Blin ME, Brison O, Dutrillaux B, Debatisse M, Common fragile site profiling in epithelial and erythroid cells reveals that most recurrent cancer deletions lie in fragile sites hosting large genes, Cell Rep 2013 Aug;4(3):420-8.
• 2012
  Millot GA, Carvalho MA, Caputo SM, Vreeswijk MP, Brown MA, Webb M, Rouleau E, Neuhausen SL, Hansen Tv, Galli A, Brandão RD, Blok MJ, Velkova A, Couch FJ, Monteiro AN, , A guide for functional analysis of BRCA1 variants of uncertain significance, Hum. Mutat. 2012 Nov;33(11):1526-37.
• 2011
  Le Tallec B, Dutrillaux B, Lachages AM, Millot GA, Brison O, Debatisse M, Molecular profiling of common fragile sites in human fibroblasts, Nat. Struct. Mol. Biol. 2011 Nov;18(12):1421-3.
• 2011
  Millot GA, Berger A, Lejour V, Boulé JB, Bobo C, Cullin C, Lopes J, Stoppa-Lyonnet D, Nicolas A, Assessment of human Nter and Cter BRCA1 mutations using growth and localization assays in yeast, Hum. Mutat. 2011 Dec;32(12):1470-80.
• 2011
  Millot Gael, Comprendre et réaliser les tests statistiques à l’aide de R, 2nd edition, De Boeck editions, Bruxelles.
• 2011
  Letessier A, Millot GA, Koundrioukoff S, Lachagès AM, Vogt N, Hansen RS, Malfoy B, Brison O, Debatisse M, Cell-type-specific replication initiation programs set fragility of the FRA3B fragile site, Nature 2011 Feb;470(7332):120-3.
• 2010
  Gay S, Lachages AM, Millot GA, Courbet S, Letessier A, Debatisse M, Brison O, Nucleotide supply, not local histone acetylation, sets replication origin usage in transcribed regions, EMBO Rep. 2010 Sep;11(9):698-704.
• 2009
  Millot Gael, Comprendre et réaliser les tests statistiques à l’aide de R, De Boeck editions, Bruxelles.
• 2008
  Malak S, Wolf M, Millot GA, Mariotte E, Veyradier A, Meynard JL, Korach JM, Malot S, Bussel A, Azoulay E, Boulanger E, Galicier L, Devaux E, Eschwège V, Gallien S, Adrie C, Schlemmer B, Rondeau E, Coppo P, , Human immunodeficiency virus-associated thrombotic microangiopathies: clinical characteristics and outcome according to ADAMTS13 activity, Scand. J. Immunol. 2008 Sep;68(3):337-44.
• 2008
  Gonnet F, Bouazza B, Millot GA, Ziaei S, Garcia L, Butler-Browne GS, Mouly V, Tortajada J, Danos O, Svinartchouk F, Proteome analysis of differentiating human myoblasts by dialysis-assisted two-dimensional gel electrophoresis (DAGE), Proteomics 2008 Jan;8(2):264-78.
• 2006
  Coppo P, Wolf M, Veyradier A, Bussel A, Malot S, Millot GA, Daubin C, Bordessoule D, Pène F, Mira JP, Heshmati F, Maury E, Guidet B, Boulanger E, Galicier L, Parquet N, Vernant JP, Rondeau E, Azoulay E, Schlemmer B, , Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura, Br. J. Haematol. 2006 Jan;132(1):66-74.
• 2004
  Coppo P, Bengoufa D, Veyradier A, Wolf M, Bussel A, Millot GA, Malot S, Heshmati F, Mira JP, Boulanger E, Galicier L, Durey-Dragon MA, Frémeaux-Bacchi V, Ramakers M, Pruna A, Bordessoule D, Gouilleux V, Scrobohaci ML, Vernant JP, Moreau D, Azoulay E, Schlemmer B, Guillevin L, Lassoued K, , Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement, Medicine (Baltimore) 2004 Jul;83(4):233-44.
• 2004
  Millot GA, Vainchenker W, Duménil D, Svinarchuk F, Differential signalling of NH2-terminal flag-labelled thrombopoietin receptor activated by TPO or anti-FLAG antibodies, Cell. Signal. 2004 Mar;16(3):355-63.
• 2003
  Coppo P, Dusanter-Fourt I, Millot G, Nogueira MM, Dugray A, Bonnet ML, Mitjavila-Garcia MT, Le Pesteur D, Guilhot F, Vainchenker W, Sainteny F, Turhan AG, Constitutive and specific activation of STAT3 by BCR-ABL in embryonic stem cells, Oncogene 2003 Jun;22(26):4102-10.
• 2002
  Millot GA, Vainchenker W, Duménil D, Svinarchuk F, Distinct effects of thrombopoietin depending on a threshold level of activated Mpl in BaF-3 cells, J. Cell. Sci. 2002 Jun;115(Pt 11):2329-37.
• 2002
  Filippi MD, Porteu F, Le Pesteur F, Schiavon V, Millot GA, Vainchenker W, de Sauvage FJ, Dubart Kupperschmitt A, Sainteny F, Requirement for mitogen-activated protein kinase activation in the response of embryonic stem cell-derived hematopoietic cells to thrombopoietin in vitro, Blood 2002 Feb;99(4):1174-82.
• 2002
  Millot GA, Feger F, Garçon L, Vainchenker W, Dumenil D, Svinarchuk F, MplK, a natural variant of the thrombopoietin receptor with a truncated cytoplasmic domain, binds thrombopoietin but does not interfere with thrombopoietin-mediated cell growth, Exp. Hematol. 2002 Feb;30(2):166-75.
• 2001
  Millot GA, Svinarchuk F, Lacout C, Vainchenker W, Dumenil D, The granulocyte colony-stimulating factor receptor supports erythroid differentiation in the absence of the erythropoietin receptor or Stat5, Br. J. Haematol. 2001 Feb;112(2):449-58.